(Q34047291)

30 July 2017

1 reference

title

Role of the peroxisome proliferator-activated receptors (PPAR) in atherosclerosis (English)

1 reference

30 July 2017

1 reference

3

1 reference

30 July 2017

Neve BP

1

1 reference

PubMed ID

11007963

30 July 2017

Fruchart JC

series ordinal

2

1 reference

PubMed ID

11007963

30 July 2017

language of work or name

English

0 references

publication date

1 October 2000

1 reference

30 July 2017

Biochemical Pharmacology

1 reference

30 July 2017

60

1 reference

30 July 2017

1245-1250

1 reference

30 July 2017

8

1 reference

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

30 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Expression of the peroxisome proliferator-activated receptor (PPAR) in the mouse colonic mucosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Macrophages in human atheroma contain PPARgamma: differentiation-dependent peroxisomal proliferator-activated receptor gamma(PPARgamma) expression and reduction of MMP-9 activity through PPARgamma activation in mononuclear phagocytes in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Polarity and specific sequence requirements of peroxisome proliferator-activated receptor (PPAR)/retinoid X receptor heterodimer binding to DNA. A functional analysis of the malic enzyme gene PPAR response element

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Multiple parameters determine the specificity of transcriptional response by nuclear receptors HNF-4, ARP-1, PPAR, RAR and RXR through common response elements.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

The PPARalpha-leukotriene B4 pathway to inflammation control.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

15-Deoxy-delta 12, 14-prostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of PPARgamma coactivator-1 through transcription factor docking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Regulation of the transcriptional activity of the peroxisome proliferator-activated receptor alpha by phosphorylation of a ligand-independent trans-activating domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Transcriptional activation by peroxisome proliferator-activated receptor gamma is inhibited by phosphorylation at a consensus mitogen-activated protein kinase site

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Regulation of peroxisome proliferator-activated receptor gamma activity by mitogen-activated protein kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

c-Jun N-terminal kinase phosphorylates peroxisome proliferator-activated receptor-gamma1 and negatively regulates its transcriptional activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Prostaglandins promote and block adipogenesis through opposing effects on peroxisome proliferator-activated receptor gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Interdomain communication regulating ligand binding by PPAR-gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome Proliferator-activated Receptor α Negatively Regulates the Vascular Inflammatory Gene Response by Negative Cross-talk with Transcription Factors NF-κB and AP-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Cross-talk between janus kinase-signal transducer and activator of transcription (JAK-STAT) and peroxisome proliferator-activated receptor-alpha (PPARalpha) signaling pathways. Growth hormone inhibition of pparalpha transcriptional activity mediated

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor alpha and gamma activators in a tissue- and inducer-specific manner.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Mechanism of action of fibrates on lipid and lipoprotein metabolism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

A mitochondrial ketogenic enzyme regulates its gene expression by association with the nuclear hormone receptor PPARalpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptors gamma and alpha mediate in vivo regulation of uncoupling protein (UCP-1, UCP-2, UCP-3) gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

PPARalpha activation by Wy 14643 induces transactivation of the rat UCP-1 promoter without increasing UCP-1 mRNA levels and attenuates PPARgamma-mediated increases in UCP-1 mRNA levels induced by rosiglitazone in fetal rat brown adipocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptor alpha mediates the adaptive response to fasting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Transcriptional control of adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

PPAR gamma and the control of adipogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

PPARγ Is Required for the Differentiation of Adipose Tissue In Vivo and In Vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

The role of plaque rupture and thrombosis in coronary artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Atherosclerosis — An Inflammatory Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

[Anti-atheromatous effects of fenofibrate, a hypolipidemic drug. I: Anti-atheromatous effects are independent of its hypolipidemic effect in cholesterol-fed rabbits]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of proliferator-activated receptors alpha and gamma induces apoptosis of human monocyte-derived macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Regulation of macrophage gene expression by peroxisome-proliferator-activated receptor gamma: implications for cardiovascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Thiazolidinedione inhibits the production of monocyte chemoattractant protein-1 in cytokine-treated human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Activation of the peroxisome proliferator-activated receptor γ promotes the development of colon tumors in C57BL/6J-APCMin/+ mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

A tale of two diseases: atherosclerosis and rheumatoid arthritis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2800%2900430-5

10.1016/S0006-2952(00)00430-5

7 January 2021

Identifiers

DOI

1 reference

30 July 2017

1 reference

PubMed ID

11007963